Categories AlphaGraphs, Earnings, Health Care
AbbVie Q4 2024 adjusted earnings decline despite 6% revenue growth
Biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) announced fourth-quarter 2024 financial results, reporting a double-digit dip in adjusted earnings and an increase in revenues.
The company reported worldwide net revenues of $15.1 billion for the December quarter, up 6% from the corresponding period of 2023. The main operating segments registered growth.
Net income, adjusted for special items, declined to $2.16 per share in Q4 from $2.79 per share in the year-ago quarter. On a reported basis, it was a net loss of $22 million or $0.02 per share in the fourth quarter, compared to a profit of $822 million or $0.46 per share last year.
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Key metrics from Kroger’s (KR) Q3 2025 earnings results
The Kroger Co. (NYSE: KR) reported its third quarter 2025 earnings results today. Total company sales rose to $33.9 billion from $33.6 billion in the same period last year. Identical
Dollar General (DG) Q3 2025 Earnings: Key financials and quarterly highlights
Dollar General Corporation (NYSE: DG) reported its third quarter 2025 earnings results today. Net sales increased 4.6% year-over-year to $10.65 billion. Same-store sales increased 2.5%. Net income was $282.7 million, or
HRL Earnings: All you need to know about Hormel Foods’ Q4 2025 earnings results
Hormel Foods Corporation (NYSE: HRL) reported its fourth quarter 2025 earnings results today. Net sales increased 1.5% year-over-year to $3.18 billion. Organic sales were up 2%. Net loss attributable to Hormel
